Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS
Over the past decade, enormous progress has been made in the understanding of severe congenital neutropenia (SCN), by identification of several causal gene mutations: in ELANE, GFI1, HAX1, WAS and G3PC3. SCN is a preleukemic condition, independent of the genetic subtype. Acquired CSF3R mutations are...
Main Authors: | Peter Vandenberghe, Karolien Beel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-06-01
|
Series: | Pediatric Reports |
Online Access: | https://www.pagepress.org/journals/index.php/pr/article/view/2826 |
Similar Items
-
RECURRENCE OF UNDERLYING CONGENITAL NEUTROPENIA WITHOUT MDS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN A PATIENT WITH ELANE-MUTATED CONGENITAL NEUTROPENIA AND SECONDARY MDS
by: Ingrid Furlan, et al.
Published: (2023-12-01) -
Inherited predisposition to MDS/AML
by: Ana Rio Machin, et al.
Published: (2018-06-01) -
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
by: Ana Rio-Machin, et al.
Published: (2020-02-01) -
PATHWAY-DIRECTED THERAPY APPROACH IN PEDIATRIC MDS AND AML
by: Barbara De Moerloose
Published: (2023-12-01) -
Neutropenias congénitas Congenital neutropenias
by: Aramís Núñez Quintana, et al.
Published: (2004-04-01)